Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist
β Scribed by Ru-Yu Pan; Show-Li Chen; Xiao Xiao; Dai-Wei Liu; Ho-Jeng Peng; Yeou-Ping Tsao
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 840 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background The adenoβassociated virus (AAV) has many safety features that favor its use in the treatment of arthritic conditions; however, the conventional, singleβstranded vector is inefficient for gene delivery to fibroblastic cells that primarily populate articular tissues. This
Objective. To determine the efficacy of local human interleukin-1 receptor antagonist (HuIL-1Ra) gene therapy in murine collagen-induced arthritis (CIA). Methods. DBN1 mice were immunized against bovine type I1 collagen. Before the onset of arthritis, NIH/3T3 fibroblasts transfected with pMFG-IRAP